U.S. medical tech firm ProPhase Labs reached a $15.78 million market cap with over 40% pre-market gains while exploring a reverse merger with a cryptocurrency-focused firm and plans to integrate Bitcoin.
verifying reliability
No specialized terms available for this topic.